Literature DB >> 28126748

Improved Diagnostic Accuracy Using Arterial Phase CT for Lateral Cervical Lymph Node Metastasis from Papillary Thyroid Cancer.

J E Park1, J H Lee2, K H Ryu1, H S Park1, M S Chung1, H W Kim1, Y J Choi1, J H Baek1.   

Abstract

BACKGROUND AND
PURPOSE: Contrast-enhanced CT protocols for papillary thyroid cancer are yet to be optimized. Our aim was to compare the diagnostic accuracy of arterial phase CT and delayed-phase CT protocols for lateral cervical lymph node metastasis from papillary thyroid carcinoma by using the lymph node tissue attenuation.
MATERIALS AND METHODS: This retrospective study included 327 lateral cervical lymph nodes (177 metastatic and 150 benign) from 131 patients with papillary thyroid carcinoma (107 initially diagnosed and 24 recurrences). Patients underwent CT by using 1 of 3 protocols: a 70-second (A) or a 35-second (B) delay with 100 mL of iodinated IV contrast or a 25-second delay with 75 mL of IV contrast (C). Two readers independently measured and compared lymph node tissue attenuation between metastatic and benign lymph nodes. An area under the receiver operating characteristic curve analysis was performed to differentiate metastatic and benign lymph nodes after multiple comparison correction for clustered data and was compared across the protocols.
RESULTS: The difference in mean lymph node tissue attenuation between metastatic and benign lymph nodes was maximum in protocol C (P < .001 for both readers). Protocol C showed the highest diagnostic performance (area under the receiver operating characteristic curve, 0.88-0.92) compared with protocol A (area under the receiver operating characteristic curve, 0.73-0.74, P < .001 for both readers) and B (area under the receiver operating characteristic curve, .63-0.65, P < .01 for both readers). The sensitivity, specificity, positive predictive value, and negative predictive value of lymph node tissue attenuation by using a 99-HU cutoff value were 83%-87%, 93.7%-97.9%, 95.1%-97.3%, and 81.2%-87%.
CONCLUSIONS: A combination of 25-second delay CT and 75 mL of iodinated IV contrast can improve the diagnostic accuracy for lateral lymph node metastasis from papillary thyroid carcinoma compared with a combination of a 35- or 70-second delay with 100-mL of iodinated IV contrast.
© 2017 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2017        PMID: 28126748     DOI: 10.3174/ajnr.A5054

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  14 in total

1.  Diagnostic performance of CT in detection of metastatic cervical lymph nodes in patients with thyroid cancer: a systematic review and meta-analysis.

Authors:  Se Jin Cho; Chong Hyun Suh; Jung Hwan Baek; Sae Rom Chung; Young Jun Choi; Jeong Hyun Lee
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

2.  Iodine Maps from Dual-Energy CT to Predict Extrathyroidal Extension and Recurrence in Papillary Thyroid Cancer Based on a Radiomics Approach.

Authors:  X-Q Xu; Y Zhou; G-Y Su; X-W Tao; Y-Q Ge; Y Si; M-P Shen; F-Y Wu
Journal:  AJNR Am J Neuroradiol       Date:  2022-04-14       Impact factor: 3.825

3.  Extracellular Volume Fraction Derived From Dual-Layer Spectral Detector Computed Tomography for Diagnosing Cervical Lymph Nodes Metastasis in Patients With Papillary Thyroid Cancer: A Preliminary Study.

Authors:  Yan Zhou; Di Geng; Guo-Yi Su; Xing-Biao Chen; Yan Si; Mei-Ping Shen; Xiao-Quan Xu; Fei-Yun Wu
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

4.  Prediction of cervical lymph node metastasis with contrast-enhanced ultrasound and association between presence of BRAFV600E and extrathyroidal extension in papillary thyroid carcinoma.

Authors:  Jia Zhan; Long-Hui Zhang; Qing Yu; Chao-Lun Li; Yue Chen; Wen-Ping Wang; Hong Ding
Journal:  Ther Adv Med Oncol       Date:  2020-08-06       Impact factor: 8.168

5.  Diagnostic accuracy of single-source dual-energy computed tomography and ultrasonography for detection of lateral cervical lymph node metastases of papillary thyroid carcinoma.

Authors:  Lin Li; Sai-Nan Cheng; Yan-Feng Zhao; Xiao-Yi Wang; De-Hong Luo; Yong Wang
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

6.  Dual-energy computed tomography could reliably differentiate metastatic from non-metastatic lymph nodes of less than 0.5 cm in patients with papillary thyroid carcinoma.

Authors:  Ying Zou; Meizhu Zheng; Ziyu Qi; Yu Guo; Xiaodong Ji; Lixiang Huang; Yan Gong; Xiudi Lu; Guolin Ma; Shuang Xia
Journal:  Quant Imaging Med Surg       Date:  2021-04

7.  Using Diffusion-Weighted MRI to Predict Central Lymph Node Metastasis in Papillary Thyroid Carcinoma: A Feasibility Study.

Authors:  Heng Zhang; Shudong Hu; Xian Wang; Wenhua Liu; Junlin He; Zongqiong Sun; Yuxi Ge; Weiqiang Dou
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-12       Impact factor: 5.555

8.  Prediction of Cervical Lymph Node Metastasis Using MRI Radiomics Approach in Papillary Thyroid Carcinoma: A Feasibility Study.

Authors:  Heng Zhang; Shudong Hu; Xian Wang; Junlin He; Wenhua Liu; Chunjing Yu; Zongqiong Sun; Yuxi Ge; Shaofeng Duan
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

9.  Prediction of ipsilateral lateral cervical lymph node metastasis in papillary thyroid carcinoma: a combined dual-energy CT and thyroid function indicators study.

Authors:  Ying Zou; Huanlei Zhang; Wenfei Li; Yu Guo; Fang Sun; Yan Shi; Yan Gong; Xiudi Lu; Wei Wang; Shuang Xia
Journal:  BMC Cancer       Date:  2021-03-04       Impact factor: 4.430

10.  Assessment of Effective Dose Received in Various Computed Tomography Protocols and Factors Affecting It.

Authors:  Vikrant Kumar; Sachin Tayal; Abbas Ali; Arun Gandhi
Journal:  Indian J Nucl Med       Date:  2021-03-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.